Company Profile
RxSight Stock Price, News & Analysis
- Ticker:
- RXST
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
6.08 USD (-3.34%)
Close
Last updated: August 6, 2026
204M USD
Market cap
Why the stock is moving
Following the latest company update, “RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook”, RXST closed down 3.34% at $6.08 on Aug 6, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Adjustable Cataract Lenses
RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery.
Light Adjustable Lens System
The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the patient's refractive outcome.
Installed-Base Model
RxSight sells capital equipment to eye-care practices and generates recurring revenue from lenses and procedure-related accessories used across the installed base.
Future catalysts
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story. The company’s stock tends to respond to evidence that procedure adoption is still widening.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of RxSight (RXST)?
RxSight (RXST) most recently closed at 6.08 USD, a -3.34% move versus the previous session.
What is the market cap of RxSight (RXST)?
RxSight currently has a market capitalization of 204M USD on BioPharmSignal.
What does RxSight do?
Adjustable Cataract Lenses RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery. Light Adjustable Lens System The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the patient's refractive...
On which exchange is RXST stock listed?
RxSight (RXST) is associated with NASDAQ, United States, Biopharma.
What is Adjustable?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.
Which conditions is RxSight targeting with Adjustable?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.
How does RxSight describe recent progress with Adjustable?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.
What is Cataract?
Adjustable Cataract Lenses RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery.